Regulation of β-adrenergic receptor function: An emphasis on receptor resensitization

Cell Cycle

Volumn 10, Issue 21, 2011, Pages 3684-3691

  Vasudevan, Neelakantan T ^a   Mohan, Maradumane L ^a   Goswami, Shyamal K ^b   Naga Prasad, Sathyamangla V ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Desensitization; G protein coupled receptor kinases; G protein coupled receptors; Phosphoinositide 3 kinase; Protein phosphatase 2A; Resensitization; adrenergic receptors; arrestin

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ARRESTIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A;

OXIDATIVE STRESS; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 80655140584     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.21.18042     Document Type: Review

References (74)

1. Magalhaes AC, Dunn H, Ferguson SS. Regulation of G protein-coupled receptor activity, trafficking and localization by Gpcr-interacting proteins. Br J Pharmacol 2011; Epub ahead of print; PMID:21699508; DOI:10.1111/j.1476-5381. 2011.01552.x.
2. Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 2001; 53:1-24; PMID:11171937.
3. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 2002; 415:206-12; PMID:11805844; DOI:10.1038/415206a.
4. Shenoy SK, Lefkowitz RJ. β-arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci 2011; 32:521-33; PMID:21680031; DOI:10.1016/j.tips.2011.05.002.
5. Claing A, Laporte SA, Caron MG, Lefkowitz RJ. Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and β-arrestin proteins. Prog Neurobiol 2002; 66:61-79; PMID:11900882; DOI:10.1016/S0301-0082(01)00023-5.
6. Luttrell LM, Gesty-Palmer D. Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 2010; 62:305-30; PMID:20427692; DOI:10.1124/pr.109.002436.
7. Daly CJ, McGrath JC. Previously unsuspected wide-spread cellular and tissue distribution of β-adrenoceptors and its relevance to drug action. Trends Pharmacol Sci 2011; 32:219-26; PMID:21429599; DOI:10.1016/j. tips.2011.02.008.
8. 2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses. Pharmacol Ther 2008; 117:1-29; PMID:17916379; DOI:10.1016/j. pharmthera. 2007.07.002.
9. Walker JK, Penn RB, Hanania NA, Dickey BF, Bond RA. New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma. Br J Pharmacol 2011; 163:18-28; PMID:21175591; DOI:10.1111/j.1476-5381.2010.01178.x.
10. Shore SA, Drazen JM. B-agonists and asthma: too much of a good thing? J Clin Invest 2003; 112:495-7; PMID:12925688.
11. Schuller HM. β-adrenergic signaling, a novel target for cancer therapy? Oncotarget 2010; 1:466-9; PMID:21317444.
12. Powe DG, Voss MJ, Zanker KS, Habashy HO, Green AR, Ellis IO, et al. B-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 2010; 1:628-38; PMID:21317458.
13. Shore SA, Moore PE. Regulation of β-adrenergic responses in airway smooth muscle. Respir Physiol Neurobiol 2003; 137:179-95; PMID:14516725; DOI:10.1016/S1569-9048(03)00146-0.
14. Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997; 390:88-91; PMID:9363896; DOI:10.1038/36362.
15. Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 2010; 9:373-86; PMID:20431569; DOI:10.1038/nrd3024.
16. Kendall RT, Strungs EG, Rachidi SM, Lee MH, El-Shewy HM, Luttrell DK, et al. The β-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1, Ile4, Ile8] angiotensin II regulates a robust G protein-independent signaling network. J Biol Chem 2011; 286:19880-91; PMID:21502318; DOI:10.1074/jbc.M111.233080.
17. Lefkowitz RJ, Pitcher J, Krueger K, Daaka Y. Mechanisms of β-adrenergic receptor desensitization and resensitization. Adv Pharmacol 1998; 42:416-20; PMID:9327928; DOI:10.1016/S1054-3589(08)60777-2.
18. Benovic JL, Pike LJ, Cerione RA, Staniszewski C, Yoshimasa T, Codina J, et al. Phosphorylation of the mammalian β-adrenergic receptor by cyclic AMP-dependent protein kinase. Regulation of the rate of receptor phosphorylation and dephosphorylation by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein. J Biol Chem 1985; 260:7094-101; PMID:2987243.
19. Dorn GW, 2nd. GRK mythology: G protein receptor kinases in cardiovascular disease. J Mol Med (Berl) 2009; 87:455-63; PMID:19229505.
20. Lefkowitz RJ. G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J Biol Chem 1998; 273:18677-80; PMID:9668034; DOI:10.1074/jbc.273.30.18677.
21. Drake MT, Shenoy SK, Lefkowitz RJ. Trafficking of G protein-coupled receptors. Circ Res 2006; 99:570-82; PMID:16973913; DOI:10.1161/01. RES.0000242563.47507.ce.
22. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 2004; 95:1140-53; PMID:15591236; DOI:10.1161/01.RES.0000150734.79804.92.
23. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA 1989; 86:6753-7; PMID:2549546; DOI:10.1073/pnas.86.17. 6753.
24. Santos CX, Anilkumar N, Zhang M, Brewer AC, Shah AM. Redox signaling in cardiac myocytes. Free Radic Biol Med 2011; 50:777-93; PMID:21236334; DOI:10.1016/j.freeradbiomed.2011.01.003.
25. Nediani C, Raimondi L, Borchi E, Cerbai E. Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications. Antioxid Redox Signal 2011; 14:289-331; PMID:20624031; DOI:10.1089/ars.2010.3198.
26. Donoso P, Sanchez G, Bull R, Hidalgo C. Modulation of cardiac ryanodine receptor activity by ROS and RNS. Front Biosci 2011; 16:553-67; PMID:21196188; DOI:10.2741/3705.
27. Gupta MK, Neelakantan TV, Sanghamitra M, Tyagi RK, Dinda A, Maulik S, et al. An assessment of the role of reactive oxygen species and redox signaling in norepinephrine-induced apoptosis and hypertrophy of H9c2 cardiac myoblasts. Antioxid Redox Signal 2006; 8:1081-93; PMID:16771697; DOI:10.1089/ars.2006.8. 1081.
28. Shclinks alpha1-adrenergic receptors to a reactive oxygen species-dependent AKT-FOXO3A phosphorylation pathway in cardiomyocytes. Circ Res 2009; 104:660-9; PMID:19168439; DOI:10.1161/CIRCRESAHA.108.186288.
29. Xu Q, Dalic A, Fang L, Kiriazis H, Ritchie RH, Sim K, et al. Myocardial oxidative stress contributes to transgenic β-adrenoceptor activation-induced cardiomyopathy and heart failure. Br J Pharmacol 2011; 162:1012-28; PMID:20955367; DOI:10.1111/j.1476-5381.2010.01043.x.
30. Flohé L. Changing paradigms in thiology from antioxidant defense toward redox regulation. Methods Enzymol 2010; 473:1-39; PMID:20513470; DOI:10.1016/S0076-6879(10)73001-9.
31. Rudolph V, Freeman BA. Cardiovascular consequences when nitric oxide and lipid signaling converge. Circ Res 2009; 105:511-22; PMID:19745170; DOI:10.1161/CIRCRESAHA.109.202077.
32. Whalen EJ, Foster MW, Matsumoto A, Ozawa K, Violin JD, Que LG, et al. Regulation of β-adrenergic receptor signaling by S-nitrosylation of G protein-coupled receptor kinase 2. Cell 2007; 129:511-22; PMID:17482545; DOI:10.1016/j.cell.2007.02.046.
33. Ozawa K, Whalen EJ, Nelson CD, Mu Y, Hess DT, Lefkowitz RJ, et al. S-nitrosylation of β-arrestin regulates β-adrenergic receptor trafficking. Mol Cell 2008; 31:395-405; PMID:18691971; DOI:10.1016/j. molcel.2008.05.024.
34. Wang G, Moniri NH, Ozawa K, Stamler JS, Daaka Y. Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proc Natl Acad Sci USA 2006; 103:1295-300; PMID:16432212; DOI:10.1073/pnas.0508354103.
35. 2 adrenoceptor agonists in isolated guinea pig trachea. J Pharmacol Exp Ther 1997; 280:332-45; PMID:8996214.
36. Ferguson SS, Caron MG. G protein-coupled receptor adaptation mechanisms. Semin Cell Dev Biol 1998; 9:119-27; PMID:9599406; DOI:10.1006/scdb.1997.0216.
37. Merrifield CJ, Moss SE, Ballestrem C, Imhof BA, Giese G, Wunderlich I, et al. Endocytic vesicles move at the tips of actin tails in cultured mast cells. Nat Cell Biol 1999; 1:72-4; PMID:10559868; DOI:10.1038/9048.
38. Naga Prasad SV, Jayatilleke A, Madamanchi A, Rockman HA. Protein kinase activity of phosphoinositide-3-kinase regulates β-adrenergic receptor endocytosis. Nat Cell Biol 2005; 7:785-96; PMID:16094730; DOI:10.1038/ncb1278.
39. Seachrist JL, Anborgh PH, Ferguson SS. β2-adrenergic receptor internalization, endosomal sorting and plasma membrane recycling are regulated by rab GTPases. J Biol Chem 2000; 275:27221-8; PMID:10854436.
40. Seachrist JL, Ferguson SS. Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. Life Sci 2003; 74:225-35; PMID:14607250; DOI:10.1016/j.lfs.2003.09.009.
41. 1-adrenergic receptor interactions with PDZ scaffold proteins. J Biol Chem 2006; 281:2820-7; PMID:16316992; DOI:10.1074/jbc.M509503200.
42. 1 adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes. J Biol Chem 2002; 277:33783-90; PMID:12097326; DOI:10.1074/jbc.M204136200.
43. 1-adrenergic receptor association with PSD-95. Inhibition of receptor internalization and facilitation of β1-adrenergic receptor interaction with N-methyl-D-aspartate receptors. J Biol Chem 2000; 275:38659-66; PMID:10995758; DOI:10.1074/jbc. M005938200.
44. Gardner LA, Naren AP, Bahouth SW. Assembly of an SAP97-AKAP79-cAMP- dependent protein kinase scaffold at the type 1 PSD-95/DLG/ZO1 motif of the human β(1)-adrenergic receptor generates a receptosome involved in receptor recycling and networking. J Biol Chem 2007; 282:5085-99; PMID:17170109; DOI:10.1074/jbc.M608871200.
45. 2-adrenergic receptor dephosphorylation by vesicular acidification. J Biol Chem 1997; 272:5-8; PMID:8995214; DOI:10.1074/jbc.272.1.5.
46. 2-adrenergic receptor sequestration. J Biol Chem 1994; 269:2790-5; PMID:7507928.
47. Sibley DR, Strasser RH, Benovic JL, Daniel K, Lefkowitz RJ. Phosphorylation/dephosphorylation of the β-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution. Proc Natl Acad Sci USA 1986; 83:9408-12; PMID:3025843; DOI:10.1073/pnas.83.24.9408.
48. Yu SS, Lefkowitz RJ, Hausdorff WP. β-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. J Biol Chem 1993; 268:337-41; PMID:8380158.
49. 2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. J Biol Chem 1997; 272:27005-14; PMID:9341139; DOI:10.1074/jbc.272.43.27005.
50. Zhang J, Barak LS, Anborgh PH, Laporte SA, Caron MG, Ferguson SS. Cellular trafficking of G proteincoupled receptor/β-arrestin endocytic complexes. J Biol Chem 1999; 274:10999-1006; PMID:10196181; DOI:10.1074/jbc.274. 16.10999.
51. 2-adrenergic receptors permit receptor resensitization. Mol Pharmacol 1995; 47:666-76; PMID:7723728.
52. Tran TM, Friedman J, Qunaibi E, Baameur F, Moore RH, Clark RB. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the β2-adrenergic receptor using phosphoserine-specific antibodies. Mol Pharmacol 2004; 65:196-206; PMID:14722251; DOI:10.1124/mol.65.1.196.
53. Kelly E. G protein-coupled receptor dephosphorylation at the cell surface. Br J Pharmacol 2006; 147:235-6; PMID:16331287; DOI:10.1038/sj.bjp. 0706553.
54. Iyer VS, Canty JM Jr. Regional desensitization of β-adrenergic receptor signaling in swine with chronic hibernating myocardium. Circ Res 2005; 97:789-95; PMID:16141409; DOI:10.1161/01. RES.0000184675.80217.9e.
55. 2-adrenergic receptor dephosphorylation: Comparison with the rate of resensitization. Mol Pharmacol 2007; 71:47-60; PMID:17012621; DOI:10.1124/mol.106.028456.
56. 2-adrenoceptor sites Ser262 and Ser355,356. Br J Pharmacol 2006; 147:249-59; PMID:16331289; DOI:10.1038/sj.bjp.0706551.
57. 2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem 1999; 274:1588-95; PMID:9880537; DOI:10.1074/jbc.274.3.1588.
58. 2-adrenergic receptor desensitization and resensitization. J Biol Chem 2000; 275:19025-34; PMID:10858453; DOI:10.1074/jbc.275.25.19025.
59. 2-adrenergic receptor. EMBO J 2003; 22:6419-29; PMID:14657015; DOI:10.1093/emboj/cdg628.
60. Fraser ID, Cong M, Kim J, Rollins EN, Daaka Y, Lefkowitz RJ, et al. Assembly of an A kinase-anchoring protein-β(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr Biol 2000; 10:409-12. (Pubitemid 30213389)
61. Cong M, Perry SJ, Lin FT, Fraser ID, Hu LA, Chen W, et al. Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. J Biol Chem 2001; 276:15192-9; PMID:11278469; DOI:10.1074/jbc.M009130200.
62. Tao J, Malbon CC. G protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential signaling to MAPK and GPCR recycling. J Mol Signal 2008; 3:19; PMID:19055733; DOI:10.1186/1750-2187-3-19.
63. Nienaber JJ, Tachibana H, Naga Prasad SV, Esposito G, Wu D, Mao L, et al. Inhibition of receptor-localized PI3K preserves cardiac β-adrenergic receptor function and ameliorates pressure overload heart failure. J Clin Invest 2003; 112:1067-79; PMID:14523044.
64. Oudit GY, Crackower MA, Eriksson U, Sarao R, Kozieradzki I, Sasaki T, et al. Phosphoinositide-3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. Circulation 2003; 108:2147-52; PMID:12963636; DOI:10.1161/01. CIR.0000091403.62293.2B.
65. Patrucco E, Notte A, Barberis L, Selvetella G, Maffei A, Brancaccio M, et al. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 2004; 118:375-87; PMID:15294162; DOI:10.1016/j. cell.2004.07.017.
66. Naga Prasad SV, Barak LS, Rapacciuolo A, Caron MG, Rockman HA. Agonist-dependent recruitment of phosphoinositide-3-kinase to the membrane by β-adrenergic receptor kinase 1. A role in receptor sequestration. J Biol Chem 2001; 276:18953-9; PMID:11259422; DOI:10.1074/jbc.M102376200.
67. Vasudevan NT, Mohan ML, Gupta MK, Hussain AK, Naga Prasad SV. Inhibition of protein phosphatase 2A activity by PI3Kgamma regulates β-adrenergic receptor function. Mol Cell 2011; 41:636-48; PMID:21419339; DOI:10.1016/j. molcel.2011.02.025.
68. 2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/β-arrestin complex. J Cell Biol 2002; 158:563-75; PMID:12163475; DOI:10.1083/jcb.200202113.
69. Arttamangkul S, Torrecilla M, Kobayashi K, Okano H, Williams JT. Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures. J Neurosci 2006; 26:4118-25; PMID:16611829; DOI:10.1523/JNEUROSCI.0303-06.2006.
70. Dang VC, Chieng B, Azriel Y, Christie MJ. Cellular morphine tolerance produced by βarrestin-2-dependent impairment of mu-opioid receptor resensitization. J Neurosci 2011; 31:7122-30; PMID:21562274; DOI:10.1523/JNEUROSCI.5999-10.2011.
71. Gray JA, Sheffler DJ, Bhatnagar A, Woods JA, Hufeisen SJ, Benovic JL, et al. Cell-type specific effects of endocytosis inhibitors on 5- hydroxytryptamine(2A) receptor desensitization and resensitization reveal an arrestin-, GRK2- and GRK5-independent mode of regulation in human embryonic kidney 293 cells. Mol Pharmacol 2001; 60:1020-30; PMID:11641430.
72. 2-adrenergic receptor phosphorylation and internalization. Am J Respir Cell Mol Biol 2007; 36:254-61; PMID:16980556; DOI:10.1165/rcmb.2006-0158OC.
73. Naga Prasad SV, Esposito G, Mao L, Koch WJ, Rockman HA. Gβgamma-dependent phosphoinositide-3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem 2000; 275:4693-8; PMID:10671499; DOI:10.1074/jbc.275.7.4693.
74. Bristow MR. Why does the myocardium fail? Insights from basic science. Lancet 1998; 352:8-14; PMID:9736474; DOI:10.1016/S0140-6736(98)90311-7.